tyrosine and Akinetic-Rigid Variant of Huntington Disease

tyrosine has been researched along with Akinetic-Rigid Variant of Huntington Disease in 24 studies

Research

Studies (24)

TimeframeStudies, this research(%)All Research%
pre-19909 (37.50)18.7374
1990's4 (16.67)18.2507
2000's8 (33.33)29.6817
2010's2 (8.33)24.3611
2020's1 (4.17)2.80

Authors

AuthorsStudies
Bandookwala, M; Sengupta, P1
Burman, J; Emami Khoonsari, P; Herman, S; Kultima, K; Landtblom, AM; Niemelä, V; Nyholm, D; Spjuth, O; Sundblom, J1
Jia, JP; Li, D; Tang, Y; Xu, EH1
Agüera, E; Cruz-Guerrero, A; Fernández-Bolaños, R; Gascón-Luna, F; Sánchez, FM; Sánchez-López, F; Tasset, I; Túnez, I1
Apostol, BL; Bates, GP; Cha, JH; DeJohn, MM; Dunah, AW; Farrell, LA; Luthi-Carter, R; Standaert, DG; Thompson, LM; Young, AB1
Kim, SU; McLarnon, JG; Ryu, JK1
Choi, DK; Heinecke, JW; Jackson-Lewis, V; Pennathur, S; Perier, C; Przedborski, S; Teismann, P; Tieu, K; Vila, M; Vonsattel, JP; Wu, DC1
Ali, SF; Galván-Arzate, S; González-Cortés, C; Medina-Campos, ON; Pedraza-Chaverrí, J; Pérez-De La Cruz, V; Pérez-Severiano, F; Santamaría, A1
Beal, MF; Galpern, WR; Isacson, O; Matthews, RT1
Beal, MF; Ferrante, RJ; Jenkins, BG; Kaddurah-Daouk, R; Matthews, RT; Rosen, BR; Yang, L1
Andersen, JK; Andreassen, OA; Beal, MF; Bogdanov, M; Dedeoglu, A; Ferrante, RJ; Jiang, D; Klivenyi, P; Lancelot, E; Mueller, G1
Abeles, I; Covault, J; Deckel, AW; Gary, KA; Sasso, D; Schmerler, N; Volmer, P; Watts, D; Weiner, R; Yan, Z1
Deckel, AW; Freitas, R; Gary, KA; Gordinier, A; Kuwada, C; Nuttal, D; Tang, V1
Gerbeaux, J; Labrune, B; Tournier, G1
Beal, MF; Bird, ED; Matson, WR; Milbury, P; Ogawa, T; Ryan, EA; Storey, E1
Beal, MF; Bird, ED; Gamache, PH; Matson, WR; Swartz, KJ1
Baskin, F; Rosenberg, RN1
Cotzias, GC; Gellene, R; Papavasiliou, PS1
Diamond, S; Hansen, S; Perry, TL; Stedman, D1
Insarova, NG1
Ottosson, JO; Rapp, W1
Hansen, S; Lesk, D; Perry, TL1
Davidson, D; Magill, BE; Murray, LG; Pullar, IA; Wilson, H; Yates, CM1
Constantinidis, J1

Reviews

2 review(s) available for tyrosine and Akinetic-Rigid Variant of Huntington Disease

ArticleYear
3-Nitrotyrosine: a versatile oxidative stress biomarker for major neurodegenerative diseases.
    The International journal of neuroscience, 2020, Volume: 130, Issue:10

    Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Biomarkers; Humans; Huntington Disease; Parkinson Disease; Prion Diseases; Tyrosine

2020
[Pediatrics in 1976].
    La Revue du praticien, 1977, Jan-21, Volume: 27, Issue:5

    Topics: Adolescent; alpha 1-Antitrypsin Deficiency; Body Weight; Carcinoma, Hepatocellular; Catheterization; Child; Child, Preschool; Glycine max; Haemophilus Infections; Humans; Huntington Disease; Infant; Infant, Newborn; Levamisole; Liver Neoplasms; Malabsorption Syndromes; Mucocutaneous Lymph Node Syndrome; Nitrites; Obesity; Pediatrics; Pericarditis; Sepsis; Splenectomy; Tyrosine; Urinary Tract Infections

1977

Trials

1 trial(s) available for tyrosine and Akinetic-Rigid Variant of Huntington Disease

ArticleYear
Modification of Parkinsonism--chronic treatment with L-dopa.
    The New England journal of medicine, 1969, Feb-13, Volume: 280, Issue:7

    Topics: Adult; Aged; Agranulocytosis; Aromatic Amino Acid Decarboxylase Inhibitors; Blood Urea Nitrogen; Blood-Brain Barrier; Chronic Disease; Dihydroxyphenylalanine; Dopamine; Feeding and Eating Disorders; Female; Humans; Huntington Disease; Male; Manganese; Mental Processes; Methyldopa; Middle Aged; Movement Disorders; Nausea; Neurologic Manifestations; Parkinson Disease; Phenylacetates; Placebos; Thyroid Function Tests; Tyrosine; Vomiting

1969

Other Studies

21 other study(ies) available for tyrosine and Akinetic-Rigid Variant of Huntington Disease

ArticleYear
Alterations in the tyrosine and phenylalanine pathways revealed by biochemical profiling in cerebrospinal fluid of Huntington's disease subjects.
    Scientific reports, 2019, 03-11, Volume: 9, Issue:1

    Topics: Adult; Aged; Biomarkers; Dopamine; Female; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Phenylalanine; Thyroxine; Tyrosine

2019
Polymorphism of HD and UCHL-1 genes in Huntington's disease.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2009, Volume: 16, Issue:11

    Topics: Adult; Age of Onset; Aged; Alleles; Chi-Square Distribution; Family Health; Female; Gene Frequency; Genotype; Humans; Huntington Disease; Male; Middle Aged; Polymorphism, Genetic; Serine; Trinucleotide Repeat Expansion; Tyrosine; Ubiquitin Thiolesterase; Young Adult

2009
NGF and nitrosative stress in patients with Huntington's disease.
    Journal of the neurological sciences, 2012, Apr-15, Volume: 315, Issue:1-2

    Topics: Adult; Biomarkers; Female; Humans; Huntington Disease; Male; Middle Aged; Nerve Growth Factor; Nitrosation; Severity of Illness Index; Tyrosine; Young Adult

2012
Complex alteration of NMDA receptors in transgenic Huntington's disease mouse brain: analysis of mRNA and protein expression, plasma membrane association, interacting proteins, and phosphorylation.
    Neurobiology of disease, 2003, Volume: 14, Issue:3

    Topics: Actinin; Animals; Brain; Cell Membrane; Disease Models, Animal; Disks Large Homolog 4 Protein; Guanylate Kinases; Huntingtin Protein; Huntington Disease; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Mice; Mice, Transgenic; Mutation; Nerve Tissue Proteins; Nuclear Proteins; Phosphorylation; Protein Structure, Tertiary; Protein Subunits; Protein Transport; Receptors, N-Methyl-D-Aspartate; RNA, Messenger; Tyrosine

2003
Blockade of quinolinic acid-induced neurotoxicity by pyruvate is associated with inhibition of glial activation in a model of Huntington's disease.
    Experimental neurology, 2004, Volume: 187, Issue:1

    Topics: Animals; Disease Models, Animal; Drug Administration Routes; Enzyme Inhibitors; Guanidines; Huntington Disease; Lactic Acid; Male; Neostriatum; Neuroglia; Neuroprotective Agents; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Oxidative Stress; Pyruvic Acid; Quinolinic Acid; Rats; Rats, Sprague-Dawley; Stereotaxic Techniques; Tyrosine

2004
Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in mice.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2005, Jul-13, Volume: 25, Issue:28

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amyotrophic Lateral Sclerosis; Animals; Brain; Corpus Striatum; Dopamine; Drug Evaluation, Preclinical; Enzyme Induction; Humans; Huntington Disease; Hypochlorous Acid; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Tissue Proteins; Neurons; Oxidative Stress; Parkinson Disease; Parkinsonian Disorders; Peroxidase; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tyrosine

2005
Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington's disease in rats: protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinate iron (III).
    Neuroscience, 2005, Volume: 135, Issue:2

    Topics: Analysis of Variance; Animals; Behavior, Animal; Blotting, Southern; Brain Injuries; Caspase 3; Caspases; Chromatography, High Pressure Liquid; Corpus Striatum; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Electrophoresis, Agar Gel; gamma-Aminobutyric Acid; Huntington Disease; Lipid Peroxidation; Male; Mitochondria; Motor Activity; Nitric Oxide Synthase; Peroxynitrous Acid; Porphyrins; Quinolinic Acids; Radiation-Sensitizing Agents; Rats; Rats, Wistar; Rotarod Performance Test; Superoxide Dismutase; Synaptic Vesicles; Synaptosomes; Tyrosine

2005
NGF attenuates 3-nitrotyrosine formation in a 3-NP model of Huntington's disease.
    Neuroreport, 1996, Nov-04, Volume: 7, Issue:15-17

    Topics: Animals; Corpus Striatum; Disease Models, Animal; Huntington Disease; Male; Nerve Growth Factors; Nitro Compounds; Propionates; Rats; Rats, Sprague-Dawley; Tyrosine

1996
Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1998, Jan-01, Volume: 18, Issue:1

    Topics: Adenosine Triphosphate; Animals; Antihypertensive Agents; Antineoplastic Agents; Creatine; Creatinine; Disease Models, Animal; Energy Metabolism; Free Radicals; Huntington Disease; Lactates; Male; Malonates; Neostriatum; Neuroprotective Agents; Neurotoxins; Nitro Compounds; Oxidative Stress; Propionates; Rats; Rats, Sprague-Dawley; Tyrosine

1998
Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2000, Jan-01, Volume: 20, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Catechols; Convulsants; Corpus Striatum; Disease Models, Animal; Dopamine Agents; Female; Free Radicals; Glutathione; Glutathione Peroxidase; Heterozygote; Homovanillic Acid; Homozygote; Huntington Disease; Male; Malonates; Mice; Mice, Inbred Strains; Mice, Knockout; MPTP Poisoning; Nitro Compounds; Oxidative Stress; Parkinson Disease, Secondary; Propionates; Tyrosine

2000
Dietary arginine alters time of symptom onset in Huntington's disease transgenic mice.
    Brain research, 2000, Sep-01, Volume: 875, Issue:1-2

    Topics: Animals; Arginine; Blood Glucose; Brain; Cerebrovascular Circulation; Diet; Huntington Disease; Mice; Mice, Transgenic; Movement Disorders; Time Factors; Tyrosine; Weight Loss

2000
Reduced activity and protein expression of NOS in R6/2 HD transgenic mice: effects of L-NAME on symptom progression.
    Brain research, 2001, Nov-16, Volume: 919, Issue:1

    Topics: Animals; Behavior, Animal; Body Weight; Brain; Calcium-Calmodulin-Dependent Protein Kinases; Disease Models, Animal; Enzyme Inhibitors; Female; Huntington Disease; Immunohistochemistry; Male; Mice; Mice, Transgenic; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Tyrosine

2001
Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex.
    Journal of the neurological sciences, 1992, Volume: 108, Issue:1

    Topics: Aged; Alzheimer Disease; Cerebral Cortex; Energy Metabolism; Free Radicals; Humans; Huntington Disease; Kynurenic Acid; Kynurenine; Middle Aged; Parkinson Disease; Purines; Tryptophan; Tyrosine

1992
Kynurenine pathway measurements in Huntington's disease striatum: evidence for reduced formation of kynurenic acid.
    Journal of neurochemistry, 1990, Volume: 55, Issue:4

    Topics: Aged; Autopsy; Corpus Striatum; Female; Humans; Huntington Disease; Kynurenic Acid; Kynurenine; Male; Middle Aged; Putamen; Reference Values; Tryptophan; Tyrosine

1990
Dopa as an antimetabolite in Huntington's disease.
    Lancet (London, England), 1973, Mar-17, Volume: 1, Issue:7803

    Topics: Acylation; Adult; Amino Acyl-tRNA Synthetases; Antimetabolites; Basal Ganglia; Caudate Nucleus; Dihydroxyphenylalanine; Dopamine; Humans; Huntington Disease; Middle Aged; Molecular Conformation; Neurons; Proteins; RNA, Transfer; Tyrosine; Tyrosine 3-Monooxygenase

1973
Plasma-aminoacid levels in Huntington's chorea.
    Lancet (London, England), 1969, Apr-19, Volume: 1, Issue:7599

    Topics: Adult; Alanine; Amino Acids; Female; Humans; Huntington Disease; Isoleucine; Leucine; Male; Middle Aged; Proline; Schizophrenia; Tyrosine; Valine

1969
[Urinary excretion of free amino acids in families of patints with Huntington's chorea].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1969, Volume: 69, Issue:6

    Topics: Adult; Aged; Alanine; Amino Acids; Chromatography, Paper; Female; Glutamates; Humans; Huntington Disease; Male; Middle Aged; Spectrophotometry; Tyrosine

1969
Serum levels of phenylalanine and tyrosine in Huntington's chorea.
    Acta psychiatrica Scandinavica. Supplementum, 1971, Volume: 221

    Topics: Adult; Aged; Analysis of Variance; Antidepressive Agents; Body Weight; Dopamine; Female; Humans; Huntington Disease; Male; Middle Aged; Norepinephrine; Parasympatholytics; Phenylalanine; Psychotic Disorders; Reserpine; Schizophrenia; Tryptophan; Tyrosine

1971
[Plasma amino acid levels in children of patients with Huntington's chorea].
    Neurology, 1972, Volume: 22, Issue:1

    Topics: Adolescent; Adult; Alanine; Amino Acids; Child; Child, Preschool; Female; Humans; Huntington Disease; Isoleucine; Leucine; Male; Middle Aged; Proline; Schizophrenia; Tyrosine

1972
Lysosomal enzymes, amino acids and acid metabolites of amines in Huntington's chorea.
    Clinica chimica acta; international journal of clinical chemistry, 1973, Feb-28, Volume: 44, Issue:1

    Topics: Acid Phosphatase; Adult; Aged; Amines; Amino Acids; Blood Proteins; Cerebrospinal Fluid Proteins; Dopamine; Female; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Lysosomes; Male; Middle Aged; Phenylacetates; Serotonin; Sulfatases; Tryptophan; Tyrosine

1973
[Monoamines and choreic syndromes].
    Revue neurologique, 1972, Volume: 127, Issue:1

    Topics: Amines; Butyrophenones; Chorea; Diazepam; Dihydroxyphenylalanine; Dopamine; Ganglia; Globus Pallidus; Homovanillic Acid; Humans; Huntington Disease; Mental Disorders; Methyldopa; Methyltyrosines; Models, Neurological; Movement Disorders; Phenothiazines; Physostigmine; Reserpine; Thalamus; Tranquilizing Agents; Tyrosine

1972